Pfizer's Covid product sales to top $50 bln this year, investors want more
Pfizer executives said the company is in active discussions with over 100 countries about Paxlovid, and has the capacity to top 120 million courses if needed

Pfizer executives said the company is in active discussions with over 100 countries about Paxlovid, and has the capacity to top 120 million courses if needed